10-K/A: EOS Inc. Files Amendment No. 5 to Form 10-K Addressing Risks in China and Hong Kong Operations

EOS Inc. filed Amendment No. 5 to its Form 10-K to clarify risks associated with operating in China and Hong Kong, including regulatory and legal uncertainties.

Summary

• EOS Inc. has filed Amendment No. 5 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
• The amendment aims to provide clearer disclosure regarding the risks of operating in China and Hong Kong, including the need for Chinese government permissions.
• Additional risk factors related to operations and doing business in Hong Kong, China, and Taiwan have been added.
• The company's CEO and CFO have certified the report in compliance with the Sarbanes-Oxley Act of 2002.
• The amendment updates XBRL data on the cover page and includes interactive data files.
• The company's auditor has issued a going concern opinion, indicating substantial doubt about its ability to continue as an ongoing business without additional capital or revenue.
• Net sales decreased by 55% to $296,852 for the year ended December 31, 2023, compared to $652,547 in 2022.
• The net loss improved by 67% to $631,936 for the year ended December 31, 2023, compared to a net loss of $1,912,159 in 2022.
• The company had a working deficit of $1,006,911 on December 31, 2023, compared to a working deficit of $840,318 on December 31, 2022.
• As of March 27, 2024, the company employs 9 full-time employees.

Sentiment

Score: 4

Explanation: The document presents a mixed picture, with some improvement in net loss but a significant decline in sales and a going concern warning. The increased risk disclosures also contribute to a negative sentiment.

Positives

• The net loss improved by 67% to $631,936 for the year ended December 31, 2023, compared to a net loss of $1,912,159 in 2022.
• Selling, general and administrative expenses decreased by 56% to $966,486 for the year ended December 31, 2023, compared to $2,208,876 for the year ended December 31, 2022.
• Gross profit as a percentage of net sales was 65% for the year ended December 31, 2023, compared to 44% in the same period in 2022.

Negatives

• Net sales decreased by 55% to $296,852 for the year ended December 31, 2023, compared to $652,547 in 2022.
• The company had a working deficit of $1,006,911 on December 31, 2023, compared to a working deficit of $840,318 on December 31, 2022.
• The company's auditor has issued a going concern opinion, indicating substantial doubt about its ability to continue as an ongoing business without additional capital or revenue.

Risks

• The company faces risks related to the uncertainty of the interpretation and application of PRC laws and regulations.
• The company may be subject to sanctions imposed by PRC regulatory agencies if it fails to comply with their rules and regulations.
• There is uncertainty regarding the enforceability of U.S. court judgments in China, Hong Kong, and Taiwan.
• The company's auditor has issued a going concern opinion, indicating substantial doubt about its ability to continue as an ongoing business without additional capital or revenue.
• The company relies on a single operating subsidiary, Emperor Star International Trade Co., Ltd., for all its business activities.

Future Outlook

The company requires additional funding to meet its ongoing obligations and to fund its operations, and its ability to continue as a going concern is dependent on generating revenues and raising capital.

Industry Context

The company operates in the nutritional supplements and consumer products distribution industry, which is subject to changing consumer preferences, regulatory requirements, and competitive pressures.

Comparison to Industry Standards

• It's difficult to compare EOS Inc.'s performance directly to industry standards without knowing specific competitors and their financial results.
• However, the decline in net sales and the presence of a working deficit suggest that the company is underperforming compared to some of its peers.
• The company's reliance on a single operating subsidiary and its limited geographic diversification also pose challenges compared to larger, more established players in the industry.

Management Changes

Related Party Transactions

• The company has advanced funds from its directors and shareholders Yu Cheng Yang for working capital purposes.
• On December 5, 2023, the company issued 345,000,000 shares of Common Stock at fair value $0.00122 per share to Co-Innovation Group Limited to convert outstanding debt owed to Mr. Yu-Cheng YANG in the amount of $420,900.
• On December 18, 2023, the company issued 55,000,000 shares of Common Stock at fair value $0.00122 per share to non-employees to convert outstanding debt owed to Mr. Yu-Cheng YANG in the amount of $67,100.

Stakeholder Impact

• Shareholders face increased risk due to the company's going concern status and operational challenges.
• Employees may be affected by the company's financial instability.
• Customers may experience disruptions in product availability due to the company's reliance on a single operating subsidiary.

Next Steps

• The company intends to generate sufficient revenue and raise additional funds to support its operations.

Key Dates

Keywords

Form 10-K, Amendment, China, Hong Kong, Risk Factors, Financial Reporting, Sarbanes-Oxley, EOS Inc., Operations